Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
deals
6
×
fda
6
×
life sciences
national blog main
national top stories
novartis
6
×
boston top stories
clinical trials
new york blog main
new york top stories
biotech
san francisco blog main
san francisco top stories
alnylam pharmaceuticals
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
sanofi
seattle blog main
seattle top stories
startups
takeda pharmaceutical
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
amgen
astrazeneca
cancer
cancer immunotherapy
crispr
What
bio
deal
roundup
help
medicines
new
years
acquire
acquisitions
age
agreed
alzheimer’s
analytics
announced
bails
bigger
biggest
billion
biofourmis
brand
bridgebio
brings
capital
car
cash
ceo
cholesterol
collabs
come
company
compound
congress
covid
daniel
data
democrats
develop
devices
digital
divided
Language
unset
Current search:
novartis
×
deals
×
fda
×
@xconomy.com
3 years ago
Biofourmis Hauls In $100M to Scale Digital Therapeutics Globally
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
5 years ago
With $100M MeiraGTx Deal, J&J Signals Bigger Move Into Gene Therapy
@xconomy.com
5 years ago
Bio Roundup: Midterm Fallout, Alzheimer’s Search, Postpartum Panel